Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals

被引：3
|
作者：
Trudeau, Sheri [1 ]
Mendiratta, Vivek [2 ]
Dababneh, Yara [3 ]
Hollingsworth, Jennifer [2 ]
Gordon, Stuart C. [2 ,4 ]
机构：
[1] Henry Ford Hlth, Dept Publ Hlth Sci, Detroit, MI USA
[2] Henry Ford Hlth, Dept Gastroenterol & Hepatol, 2799 W Grand Blvd, Detroit, MI 48202 USA
[3] Henry Ford Hlth, Dept Internal Med, Detroit, MI USA
[4] Wayne State Univ, Sch Med, Detroit, MI USA
来源：
HEPATOLOGY | 2023年 / 77卷 / 01期
关键词：
D O I：
10.1002/hep.32688
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E9 / E10
页数：2
相关论文
共 50 条
  • [21] Unusually Aggressive Hepatocellular Carcinoma Developing After Treatment of Hepatitis C With Direct-Acting Antivirals
    Issa, Danny
    Dessie, Sofanit
    Matherly, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1184 - S1184
  • [22] HEPATITIS C VIRUS REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT-ACTING ANTIVIRAL THERAPY AMONG MSM
    Janjua, Naveed
    Wong, Stanley
    Bartlett, Sofia
    Adu, Prince
    Butt, Zahid Ahmad
    Wong, Jason
    Pearce, Margo
    Yu, Amanda
    Samji, Hasina
    Rossi, Carmine
    Alvarez, Maria Jose
    Binka, Mawuena
    Krajden, Mel
    HEPATOLOGY, 2019, 70 : 961A - 962A
  • [23] Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals
    Enomoto, Masaru
    Tateishi, Chiharu
    Tsuruta, Daisuke
    Tamori, Akihiro
    Kawada, Norifumi
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (09) : 678 - 680
  • [24] Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
    Dobrowolska, Krystyna
    Brzdek, Michal
    Rzymski, Piotr
    Flisiak, Robert
    Pawlowska, Malgorzata
    Janczura, Jakub
    Brzdek, Kinga
    Zarebska-Michaluk, Dorota
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, : 833 - 852
  • [25] Treatment of hepatitis C in HIV patients in the new era of direct-acting antivirals
    Fernández-Montero J.V.
    Vispo E.
    Barreiro P.
    De Mendoza C.
    Labarga P.
    Soriano V.
    Current Hepatitis Reports, 2013, 12 (4) : 269 - 275
  • [26] Real-World Experiences with Direct-Acting Antivirals for Hepatitis C Treatment
    Daniel, Kimberly
    Rizvi, Syed
    Saeian, Kia
    HEPATOLOGY, 2017, 66 : 840A - 841A
  • [27] Measure of adherence to direct-acting antivirals as a predictor of the effectiveness of hepatitis C treatment
    María Ángeles Campos Fernández de Sevilla
    Marta Gallego Úbeda
    Maria Tovar Pozo
    Emilio García-Cabrera
    Beatriz Monje García
    Federico Tutau Gómez
    Laura Delgado Téllez de Cepeda
    Irene Iglesias-Peinado
    International Journal of Clinical Pharmacy, 2019, 41 : 1545 - 1554
  • [28] Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources
    Marciano, S.
    Haddad, L.
    Borzi, S. M.
    D'Amico, C.
    Gaite, L. A.
    Aubone, M. V.
    Sirotinsky, M. E.
    Ratusnu, N.
    Frola, M. S.
    Aparicio, M. C.
    Rios, B.
    Anselmo, M. N.
    Hansen, R.
    De Filippi, S.
    Garcia Dans, C.
    de Labra, L.
    Peche, M. A.
    Strella, T. M.
    Ibanez Duran, M.
    Garcia Rosales, M. B.
    Dirchwolf, M.
    Galdame, O. A.
    Gadano, A. C.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2018, 83 (02): : 208 - 211
  • [29] Measure of adherence to direct-acting antivirals as a predictor of the effectiveness of hepatitis C treatment
    Campos Fernandez de Sevilla, Maria Angeles
    Gallego Ubeda, Marta
    Tovar Pozo, Maria
    Garcia-Cabrera, Emilio
    Monje Garcia, Beatriz
    Tutau Gomez, Federico
    Delgado Tellez de Cepeda, Laura
    Iglesias-Peinado, Irene
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (06) : 1545 - 1554
  • [30] Barriers to Treatment of Chronic Hepatitis C with Direct-Acting Antivirals in an Urban Clinic
    Malespin, Miguel H.
    Harris, Ciel
    Kanar, Ozdemir
    de Melo, Silvio W., Jr.
    Nelson, David R.
    Cotler, Scott
    HEPATOLOGY, 2017, 66 : 325A - 325A
12345